Everest Medicines Ltd
Everest Medicines's Climate Target Data Preview
As of 2024, Everest Medicines has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Everest Medicines's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Intensity-based Target | Scope 1 - Total, Scope 2 - Total, Scope 3 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) per Employee | Copy/Paste is a PRO feature.  a | 2030 |
Verified Sources Behind Everest Medicines’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Everest Medicines’s data sources below and access millions more through our Disclosure Search.
Insights into Everest Medicines's Greenhouse Gas Emissions Pathways
As of 2024, Everest Medicines has set greenhouse gas (GHG) emissions reduction targets that cover only its total carbon footprint, without separate targets for operational (Scope 1 and 2) or value chain (Scope 3) emissions. This limits the ability to track progress across distinct emissions categories.a
Does Everest Medicines have a target to reduce its total carbon footprint?
As of 2024, Everest Medicines has set a target to reduce its total carbon footprint, specifically those from Scope 1, Scope 2 and Scope 3 sources.a
Everest Medicines's most ambitious carbon footprint target is to reduce its scope 1, 2 and 3 emissions from a baseline of 7.41 Metric Tonnes of CO2 equivalent (mtCO2e) per Employee in 2024, by 5% by 2030.a